Skip to main navigation Skip to search Skip to main content

Reassessing carbamazepine in the treatment of bipolar disorder: Clinical implications of new data

  • David L. Ginsberg
  • , Hagop S. Akiskal
  • , Paul E. Keck
  • , Matthew A. Fuller
  • , Richard H. Weisler
  • , Robert M.A. Hirschfeld
  • , Eric Hollander

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Reassessing carbamazepine in the treatment of bipolar disorder: Clinical implications of new data'. Together they form a unique fingerprint.
Sort by

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science